Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice

European Journal of Neuroscience

Volumn 13, Issue 1, 2001, Pages 153-161

  Hutcheson, Daniel M ^b,e   Matthes, Hans W D ^c   Valjent, Emmanuel ^a   Sánchez Blázquez, Pilar ^d   Rodríguez Díaz, Marta ^d   Garzón, Javier ^d   Kieffer, Brigitte L ^c   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d CSIC   (Spain)

^e UK   (United Kingdom)

Author keywords

Delta opioid agonist; Opioid receptor; Opioid withdrawal; Place preference; Protein kinase C

Indexed keywords

DELTORPHIN; ISOENZYME; MU OPIATE RECEPTOR; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG WITHDRAWAL; IMMUNOREACTIVITY; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; REWARD;

ANIMALS; CEREBRAL CORTEX; CONDITIONING (PSYCHOLOGY); IMMUNOBLOTTING; ISOENZYMES; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OLIGOPEPTIDES; PROTEIN KINASE C; RECEPTORS, OPIOID, MU; REFERENCE VALUES; REWARD; SUBSTANCE-RELATED DISORDERS; UP-REGULATION;

EID: 0035190219     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2001.01363.x     Document Type: Article

References (61)

1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice
2. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression
3. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat
4. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice
5. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist
6. Naloxone-precipitated withdrawal in morphine-dependent rats increases the expression of alpha 2a-adrenoceptor mRNA in brain
7. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86
8. Direct dependence studies in rats with agents selective for different types of opioid receptor
9. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization
10. Angiotensin and salt appetite of BALB/c mice
11. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies
12. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats
13. Opioid receptors
14. Non-peptide delta opioid agonists and antagonists
15. Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats
16. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence
17. Regulation of immunolabelled mu-opioid receptors and protein kinase C-alpha and zeta isoforms in the frontal cortex of human opiate addicts
18. Transport of CSF antibodies to Galpha subunits across neural membranes requires binding to the target protein and protein kinase C activity
19. Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats
20. Delta-opioid receptor agonists produce antinociception and [S-35]GTPgammaS binding in mu receptor knockout mice
21. Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception
22. Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist
23. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides
24. Opioids: First lessons from knock-out mice
25. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene
26. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat
27. Dopamine-dependent behavioral stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats
28. (D-Ala2) Deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens
29. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB
30. Differences in physical dependence induced by selective mu and delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors
31. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta-, and kappa-selective opioid antagonists
32. Protein kinases in the locus coeruleus and periaquaductal gray matter are involved in the expression of opiate withdrawal
33. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
34. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor
35. Influence of chronic morphine treatment on protein kinase C activity: Comparison with butorphanol and implication for opioid tolerance
36. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse
37. Inhibition of protein kinase C but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse
38. Molecular and cellular basis of addiction
39. Chronic morphine treatment increases cyclic AMP-dependent protein kinase C activity in the rat locus coeruleus
40. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats
41. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts
42. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C
43. 2+-channel inhibitors of abstinence-induced [3H]-noradrenaline release
44. In vivo evidence for the selectivity of ICI 154129 for the delta-opioid receptor
45. Development of delta opioid peptides as non addicting analgesics
46. Allosteric coupling among opioid receptors: Evidence for an opioid receptor complex
47. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: Biochemical evidence for the existence of a mu/delta opioid receptor complex
48. Motivational properties of opioids: Evidence that an inactivation of delta-receptors mediates reinforcement processes
49. The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia
50. The effects of opioid peptides on dopamine release in the nucleus accumhens: An in vivo microdialysis study
51. Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by delta opioid receptor subtypes in mice
52. Effect of the highly selective and non-peptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice
53. Possible involvement of protein kinases in physical dependence on opioids: Studies using protein kinase inhibitors, H-7 and H-8
54. Delta-opioid receptor subtypes and cross-talk with mu-receptors
55. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal
56. Mu and delta receptors: Their role in analgesia in the differential effects of opioid peptides on analgesia
57. Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain
58. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice
59. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice
60. Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats
61. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice